Filing
Spy
Filing
Spy
Home
About
RYZB
Rayzebio Inc
Radiopharmaceutical therapeutics company focused on cancer treatment
CUSIP: 75525N107
Healthcare
US
1 holder
Ownership
Activity
2023 Q3
2 of 2 quarters
Total Value
$147.47M
Total Shares
6.64M
Net Share Change
+6.64M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$147.47M
6.64M
0.6%
NEW
Viking Global Investors
$147.47M
6.64M shares
NEW
RYZB — Rayzebio Inc - FilingSpy